Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

71 trials with published results (20%)

Research Maturity

215 completed trials (61% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.5%

16 terminated out of 355 trials

Success Rate

93.1%

+6.5% vs benchmark

Late-Stage Pipeline

23%

83 trials in Phase 3/4

Results Transparency

33%

71 of 215 completed with results

Key Signals

71 with results93% success16 terminated

Data Visualizations

Phase Distribution

208Total
Not Applicable (67)
Early P 1 (4)
P 1 (13)
P 2 (41)
P 3 (44)
P 4 (39)

Trial Status

Completed215
Unknown63
Recruiting28
Terminated16
Not Yet Recruiting14
Active Not Recruiting10

Trial Success Rate

93.1%

Benchmark: 86.5%

Based on 215 completed trials

Clinical Trials (355)

Showing 20 of 20 trials
NCT02281747Active Not Recruiting

Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries

NCT07737730Not Yet Recruiting

A Study to Assess the Safety of Subcutaneous Secukinumab for Treatment in Adult Indian Participants With Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS), and Non-Radiographic Axial Spondyloarthritis (nr-axSpA)

NCT07648836Not Yet RecruitingPrimary

Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

NCT06250062Phase 2CompletedPrimary

A Clinical Study of JS005 in Patients With Ankylosing Spondylitis

NCT04436640Phase 3Active Not Recruiting

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

NCT05570656Not ApplicableCompletedPrimary

Modeling Spinal Mobility in Ankylosing Spondylitis: Towards New Telekinetic Biomarkers

NCT07641920Not Yet RecruitingPrimary

Assessment of Peripheral Neuropathy in Ankylosing Spondylitis

NCT07632599Phase 1Not Yet RecruitingPrimary

Safety and Efficacy of Allogeneic Bone Marrow MSCs in Ankylosing Spondylitis

NCT05862584Not ApplicableCompleted

Impact of Air Pollution on the Course of Inflammatory Rheumatism

NCT04751396RecruitingPrimary

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

NCT02469753Phase 3CompletedPrimary

Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes

NCT06526377Phase 2Not Yet Recruiting

Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy

NCT05096767Active Not RecruitingPrimary

Neuropathic Spinal Pain Descriptors in Ankylosing Spondylitis

NCT07578220Not ApplicableRecruitingPrimary

Clinical Trial Study on the Improved New Method of Acupotomy for AS

NCT04809168Active Not RecruitingPrimary

Neuropathic Spinal Pain in Ankylosing Spondylitis

NCT07580092CompletedPrimary

Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease

NCT01852851Not ApplicableActive Not Recruiting

Employment and Arthritis: Making it Work

NCT07390929Not ApplicableWithdrawnPrimary

Clinical Trial Study on the Improved New Method of Acupotomy for AS

NCT07534644Phase 1Not Yet RecruitingPrimary

A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis

NCT00085995CompletedPrimary

Progression of Spinal Fusion in Ankylosing Spondylitis

Scroll to load more

Research Network

Activity Timeline